KOREA PHARMA Co., Ltd.

₩7,770As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:032300Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (9.57%)
Div yield 0.64%
ROE (1.07%)
Pharmaceutical Preparations
Beta (5Y) 0.57
PE TTM —
TSR TTM (41.04%)
Mkt cap ₩84.75B
ROIC 2.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,372
7.75%
(85.84%)
Hold 3|2|5|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
175.41
189.78
200.21
211.11
17.81%
18.12%
17.54%
19.49%
Revenue₩B
5.190
5.471
5.680
5.974
14.86%
15.20%
12.93%
12.50%
Peers (US$62.48M)
Cap (US$)
PE
60.85M
2.961x
58.45M
7.521x
Capital
TTM
5Y
10Y
Leveragex
0.185
1.389
1.134
EBIT/Intx
1.016
1.586
1.572
Own earn%
9.81
(34.00)
(43.32)
Sh yield%
10.16
35.46
31.77
Owners
Insiders/Inst%
14.61
67.34
Short interest%
5.10
SBC / revenue%
4.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–21
$1 testx
2.9
Incr. ROIC%
4